TrialLeukemia2026

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Anna B Halpern et al.PubMed ↗Publisher ↗

No numbers read from the abstract.